LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

No treatment‐related effects with aryloxyalkanoate dioxygenase‐12 in three 28‐day mouse toxicity studies

Photo by nci from unsplash

ABSTRACT The aryloxyalkanoate dioxygenase‐12 (AAD‐12) protein is expressed in genetically modified soybean events DAS‐68416‐4 and DAS‐444ϕ6‐6. Expression of the AAD‐12 protein in soybeans confers tolerance to the herbicide 2,4‐dichlorophenoxyacetic acid… Click to show full abstract

ABSTRACT The aryloxyalkanoate dioxygenase‐12 (AAD‐12) protein is expressed in genetically modified soybean events DAS‐68416‐4 and DAS‐444ϕ6‐6. Expression of the AAD‐12 protein in soybeans confers tolerance to the herbicide 2,4‐dichlorophenoxyacetic acid (2,4‐D) providing an additional herbicide choice to farmers. This enzyme acts by catalyzing the degradation of 2,4‐D into herbicidally inactive metabolites. To meet evolving interpretation of regulations in the European Union, three separate 28‐day repeat‐dose oral mouse studies were conducted at increasing doses of up to 1100 mg AAD‐12 protein/kg bw/day. No treatment‐related effects were seen in any of these three studies. HighlightsThe AAD‐12 protein is expressed in genetically modified soybeans.AAD‐12 confers herbicidal tolerance to 2,4‐D.No treatment‐related effects of AAD‐12 protein in three 28‐day mouse studies.

Keywords: aad protein; related effects; aryloxyalkanoate dioxygenase; day; treatment related

Journal Title: Regulatory Toxicology and Pharmacology
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.